Christine Chen M.D.
Dr. Christine Chen is an assistant professor at the University of Toronto (U of T) in Canada and hematology faculty at the Princess Margaret Hospital (PMH). She is part of an active clinical research group for multiple myeloma and related mature B-cell disorders at the PMH, Canada’s largest cancer treatment centre.
The Myeloma Group at PMH sees over 350 new patients per year as a major referral centre for multiple myeloma, Waldenstrom’s macroglobulinemia (WM), chronic lymphocytic leukemia (CLL) and amyloidosis. The myeloma group is active in clinical and basic science research and offers numerous trials using novel agents or approaches for patients with mature B-cell disorders.
Dr. Chen is an active clinical investigator and maintains a particular interest in novel approaches for WM and CLL. She is a member of the National Cancer Institute of Canada and sits on the myeloma site committee and various study review committees. Dr. Chen underwent her internal medicine training at the University of British Columbia in Vancouver and hematology residency training at McMaster University in Hamilton. Upon completing a transplant clinical research fellowship at PMH, she joined the faculty of the Department of Medical Oncology and Hematology at the U of T and subsequently obtained her Masters in Education from the Ontario Institute of Studies in Education/U of T. She takes an active role in education of both patients and trainees and acts as the education coordinator for the Myeloma Group and the Director of the Hematology Training Program at the University of Toronto.
WM Clinical Trials: https://clinicaltrials.gov/ct2/results?term=Christine+Chen+Waldenstrom%27s